The development of amivantamab for the treatment of non-small cell lung cancer

Những quyển sách tương tự

• Amivantamab versus standard therapies among patients with advanced non-small cell lung cancer and epidermal growth factor receptor exon 20 insertion mutations after platinum-based therapy in China
  Bằng: Lan Shen, et al.
  Được phát hành: (2025-08-01)
• Amivantamab-Vmjw: A Novel Treatment for Patients with NSCLC Harboring EGFR Exon 20 Insertion Mutation after Progression on Platinum-Based Chemotherapy
  Bằng: Vishal Shah, et al.
  Được phát hành: (2023-03-01)
• Real-world pharmacovigilance analysis unveils the toxicity profile of amivantamab targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
  Bằng: Jing Zhang, et al.
  Được phát hành: (2025-02-01)
• Targeting EGFR Exon 20 Insertion-mutated Cancers – New Perspectives in Head and Neck Cancers – Lessons to Learn from Non-small Cell Carcinoma (NSCLC)
  Bằng: Camil Ciprian MIRESTEAN, et al.
  Được phát hành: (2022-09-01)
• Molecular characteristics and responses to EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients with EGFR exon 19 insertions
  Bằng: Yang Li, et al.
  Được phát hành: (2025-04-01)